Skip to Main

Esophageal Diseases Center – Patient Care

Clinical Trials

Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer  (clinicaltrials.gov NCT04018872)

A Randomized, Multicenter, Double Blind, Phase III Study of Adjuvant Nivolumab or Placebo in Subjects with Resected Esophageal, or Gastroesophageal Junction Cancer (CheckMate 577) (clinicaltrials.gov NCT02743494)

A phase 3, randomized, 3-part study to investigate the efficacy and safety of dupilumab in adult and adolescent patients with eosinophilic esophagitis (clinicaltrials.gov NCT03633617)

An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers (clinicaltrials.gov NCT03662659)

Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer (clinicaltrials.gov NCT04592913)

Associated Clinics

Other Clinical Studies

  1. Registry and Biorepository for the Study of Eosinophilic Esophagitis

  2. Examining Lamina Propria Procurement with Various Sampling Techniques in Pediatric Eosinophilic Esophagitis Patients

  3. Retrospective and Prospective Pediatric Eosinophilic Diseases of the Gastrointestinal Tract

  4. Developing Serum Exosomes as a Biomarker in Esophageal Cancer Patients

Back-to top